<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03153969</url>
  </required_header>
  <id_info>
    <org_study_id>12486</org_study_id>
    <nct_id>NCT03153969</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of a New Giomer Restorative System in Class V Restorations</brief_title>
  <official_title>A Clinical Trial to Evaluate a New Giomer Restorative System in Class V Restorations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tufts University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shofu Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tufts University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the clinical effectiveness of a new composite&#xD;
      resin (SHOFU Beautifil II LS) vs a control (3M/ESPE Filtek Supreme) for use in restoring non&#xD;
      carious cervical lesions Class V lesions.&#xD;
&#xD;
      3M ESPE FiltekTM Supreme is one of the composite resin materials that will be used in this&#xD;
      study (Group 1). This is a light-activated, flowable restorative composite.&#xD;
&#xD;
      Shofu Beautifil II LS (SI R21204) is a new type of filling material called a Giomer. This is&#xD;
      the second composite that will be used in this study (Group 2) Giomer is a collective term&#xD;
      for dental materials that will release ions, such as fluoride. Results from previous studies&#xD;
      show that the released ions may have beneficial effects on the tooth, including strengthening&#xD;
      the tooth.&#xD;
&#xD;
      In each participant, one tooth with a class V lesion will be randomized to group 1, and a&#xD;
      second tooth with a class V lesion will be randomized to group 2. The restorations will be&#xD;
      observed over 18 months to determine clinical acceptability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-center, non-blinded, controlled, split mouth, clinical trial 18 months in&#xD;
      duration.&#xD;
&#xD;
      The purpose of this clinical trial is to evaluate the effectiveness of a new Giomer&#xD;
      restorative system (Shofu Beautifil LS) for use in restoring non carious Class V lesions by&#xD;
      comparing it to 3M ESPE FiltekTM Supreme in the following categories:&#xD;
&#xD;
      Clinical Assessments (Documentation at baseline, 6months and 18months):&#xD;
&#xD;
        -  Surface Luster&#xD;
&#xD;
        -  Surface Staining&#xD;
&#xD;
        -  Marginal Staining&#xD;
&#xD;
        -  Color Match&#xD;
&#xD;
        -  Anatomical Form&#xD;
&#xD;
        -  Marginal Adaptation&#xD;
&#xD;
        -  Fracture of Material and Retention&#xD;
&#xD;
        -  Radiographic Examination&#xD;
&#xD;
        -  Patient's View&#xD;
&#xD;
        -  Postoperative Hypersensitivity&#xD;
&#xD;
        -  Recurrence of Caries&#xD;
&#xD;
        -  Tooth Integrity&#xD;
&#xD;
        -  Adjacent Mucosa&#xD;
&#xD;
      Sensitivity interview- assessed preoperatively (prior to anesthesia, if needed) at baseline&#xD;
      and after restoration placement&#xD;
&#xD;
      Dentin Sclerosis Rating- assessed at baseline&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2017</start_date>
  <completion_date type="Anticipated">April 13, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 13, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hickel Criteria</measure>
    <time_frame>Up to 18 months</time_frame>
    <description>Clinical assessments (Esthetic properties: surface luster, surface staining, marginal staining, color match, anatomical form, Functional properties: marginal adaptation, fracture of material and retention, radiographic examination, patient's view, and Biological Properties: postoperative hypersensitivity, recurrence of caries, tooth integrity and adjacent mucosa) will be performed by two trained examiners other than the operating clinician using modified Hickel criteria at baseline and follow-up visits. Differences between the two groups for Hickel criteria items will be examined with the Wilcoxon signed-rank test.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">49</enrollment>
  <condition>Non-carious Cervical Lesions</condition>
  <arm_group>
    <arm_group_label>SHOFU Beautifil II LS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Composite: SHOFU Beautifil II LS, Bonding Agent: SHOFU BeautiBond</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3M/ESPE Filtek Supreme</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Composite: 3M/ESPE Filtek Supreme, Bonding Agent: 3M/ESPE Scotchbond Universal</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SHOFU Beautifil II LS</intervention_name>
    <description>Placed under manufacturer's instructions</description>
    <arm_group_label>SHOFU Beautifil II LS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3M/ESPE Filtek Supreme</intervention_name>
    <description>Placed under manufacturer's instructions</description>
    <arm_group_label>3M/ESPE Filtek Supreme</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older, in general health&#xD;
&#xD;
          -  Must have a minimum of 2 cervical lesions in need of restoration&#xD;
&#xD;
          -  Cervical lesions must provide for a minimum of 1mm thickness of restorative material&#xD;
             while maintaining natural tooth contour&#xD;
&#xD;
          -  At least 50% of lesion must be in dentin&#xD;
&#xD;
          -  Coronal margin of lesion must be in enamel&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Rampant uncontrolled caries&#xD;
&#xD;
          -  Systemic or local disorders that contra-indicate the dental procedures included in&#xD;
             this study&#xD;
&#xD;
          -  Evidence of xerostomia&#xD;
&#xD;
          -  Evidence of severe bruxing or clenching or in need of TMJ related therapy&#xD;
&#xD;
          -  Women who are pregnant or breast feeding (self-reported).&#xD;
&#xD;
          -  Known allergy to resin composites or local anesthetics&#xD;
&#xD;
          -  Abnormal oral soft tissue findings (e.g., open sores, lesions)&#xD;
&#xD;
          -  Condition affecting salivary flow (e.g., salivary gland disorder, Sj√∂gren's Syndrome)&#xD;
&#xD;
          -  Teeth with periapical pathology or exhibiting symptoms of pulpal pathology&#xD;
&#xD;
          -  Teeth that are non-vital or have had root canal therapy&#xD;
&#xD;
          -  Teeth that have been pulp capped&#xD;
&#xD;
          -  Teeth with near exposures on pre-operative radiographs&#xD;
&#xD;
          -  Hypersensitive teeth&#xD;
&#xD;
          -  Teeth with a periodontal pocket of more than 4mm with bleeding on probing&#xD;
&#xD;
          -  Teeth that are used as abutments for removable partial dentures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Kugel, DMD, MS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tufts University School of Dental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerard Kugel, DMD, MS, PhD</last_name>
    <phone>(617) 636-0870</phone>
    <email>gerard.kugel@tufts.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolette Kafasis</last_name>
    <phone>6176362147</phone>
    <email>dentalresearchadministration@tufts.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tufts University School of Dental Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerard Kugel</last_name>
      <phone>617-636-0870</phone>
      <email>dentalresearchadministration@tufts.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>October 14, 2021</last_update_submitted>
  <last_update_submitted_qc>October 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tufts University</investigator_affiliation>
    <investigator_full_name>Dr. Gerard Kugel</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

